Risk factors of postoperative respiratory infections in lung cancer surgery

J Thorac Oncol. 2007 Jan;2(1):34-8. doi: 10.1097/JTO.0b013e31802bafb6.

Abstract

Background: Postoperative infections have been a major issue in lung cancer surgery. We changed our perioperative prophylactic antibiotic policy to a single dose of cefazolin before and after surgery in July 2002.

Objective: To identify the risk factors of postoperative pneumonia and empyema in lung cancer patients undergoing surgical resection.

Methods: From July 1992 through September 2003, 2105 patients underwent primary lung cancer resection at our division. We reviewed 1855 eligible patients for possible risk factors of pneumonia and empyema.

Results: Postoperative respiratory infections developed in 69 (3.7%) patients. There were 58 (3.1%) pneumonia cases and 18 (1.0%) cases of empyema. The mortality rate was 0.8% (15 patients). Nine (0.5%) patients died from postoperative respiratory infections. Multivariate analysis showed age 75 years or older, forced expiratory volume in 1 second as a percentage of forced vital capacity (FEV1%) less than 70%, advanced pathologic stage, and induction therapy to be independent risk factors of pneumonia. For postoperative empyema, advanced age was the significant factor. Twelve of 18 patients (67%) with empyema were complicated with bronchopleural fistula. The infection incidence rate did not change significantly after we modified our prophylactic antibiotic policy to a single dose of cefazolin before and after surgery.

Conclusions: Lung cancer patients with advanced age, low FEV1%, advanced pathologic stage, or induction therapy had a risk for pneumonia after lung cancer surgery. Postoperative empyema was associated with advanced age.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / therapeutic use
  • Antibiotic Prophylaxis
  • Cefazolin / therapeutic use
  • Empyema, Pleural / etiology
  • Female
  • Humans
  • Lung Neoplasms / surgery*
  • Male
  • Middle Aged
  • Pneumonectomy / adverse effects*
  • Pneumonia / etiology
  • Respiratory Tract Fistula / etiology
  • Respiratory Tract Infections / etiology*
  • Respiratory Tract Infections / prevention & control
  • Risk Factors

Substances

  • Anti-Bacterial Agents
  • Cefazolin